type-2-diabetes-mellitus

Documents about type-2-diabetes-mellitus

• Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus#184782ClinicalTrials.gov
• Effects on Colesevelam HC1 (WelChol®) on Insulin Sensitivity in Subjects With Type 2 Diabetes Mellitus#208363ClinicalTrials.gov
• Diastolic Dysfunction in Patients With Type 2 Diabetes Mellitus#217183ClinicalTrials.gov
• Effects of Fats on Blood Glucose in People With and Without Type 2 Diabetes Mellitus#230365ClinicalTrials.gov
• Multiple Escalating Oral Doses Study of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus#252947ClinicalTrials.gov
• Safety and Efficacy of Vildagliptin Plus Metformin (SPC) Treatment in Type 2 Diabetes Mellitus Patients#267986ClinicalTrials.gov
• Turkish Version of The Diabetes Quality of Life Brief Clinical Inventory Validity and Reliability#217189ClinicalTrials.gov
• Conversation Map and Diabetes in Pakistan#160252ClinicalTrials.gov
• Technology Intensified Diabetes Education Study in African Americans#226183ClinicalTrials.gov
• Teplizumab in Pediatric Stage 2 Type 1 Diabetes#238266ClinicalTrials.gov
• Management of Type 2 Diabetes After Gastric Bypass Surgery#28549ClinicalTrials.gov
• Validation of a Patient Decision Aid for Type 2 Diabetes#175071ClinicalTrials.gov
• Metformin, Empagliflozin With Sitagliptin vs Linagliptin in Type 2 Diabetes#226207ClinicalTrials.gov
• A Study in Patients With Type 2 Diabetes#238303ClinicalTrials.gov
• Jejunal Ketogenesis and Type 2 Diabetes#245427ClinicalTrials.gov
• Glimepiride, Empagliflozin, and Sitagliptin With Metformin for Type 2 Diabetes#261465ClinicalTrials.gov
• The Effects of Breakfast Size on Hormonal Profile in Adults With Type 2 Diabetes Mellitus#123644ClinicalTrials.gov
• Efficacy and Safety of Insulin Rinsulin® NPH Compared to Humulin® NPH in Type 2 Diabetes Mellitus Patients#126027ClinicalTrials.gov
• Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus#136232ClinicalTrials.gov
• INV-144 Versus Losartan in Hypertension and Type 2 Diabetes Mellitus Patients With Macroalbuminuria#154762ClinicalTrials.gov
• Comparison of MyStar DoseCoach to Routine Titration in Adult Patients With Type 2 Diabetes Mellitus Using Toujeo#154840ClinicalTrials.gov
• Effect of Administration of Resveratrol on Glycemic Variability in Individuals With Type 2 Diabetes Mellitus#158172ClinicalTrials.gov
• A Study of Blood Metabolic Markers in Patients With Type 2 Diabetes Mellitus of Different Stages#162370ClinicalTrials.gov
• Effects of Liraglutide on the Cognitive Function in Patients With Type 2 Diabetes Mellitus#201637ClinicalTrials.gov
• Albiglutide Versus Placebo Added-on to Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes Mellitus#201755ClinicalTrials.gov
• Vascular Effects of Sitagliptin in Diabetes Mellitus#28523ClinicalTrials.gov
• Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin#256831ClinicalTrials.gov
• Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus#148719ClinicalTrials.gov
• Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus#160300ClinicalTrials.gov
• Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes Mellitus When Failing on OADs#146350ClinicalTrials.gov
• DIABETES MELLITUS: PATHOPHYSIOLOGY, DIAGNOSIS AND EMERGING THERAPEUTIC STRATEGIES#210168Zenodo (CERN)
• Personalised Medicine in Pre-diabetes and Early Type 2 Diabetes#195514ClinicalTrials.gov
• Prevention of Diabetes Mellitus Type 2 in Women Post Gestational Diabetes Mellitus Diagnosis#253144ClinicalTrials.gov
• Sitagliptin and Pioglitazone Mechanism of Action Study in Type 2 Diabetes Mellitus (0431-061)#18783ClinicalTrials.gov
• Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus#123388ClinicalTrials.gov
• Efficacy and Safety of Vildagliptin as add-on Therapy to Insulin in Patients With Type 2 Diabetes Mellitus#126060ClinicalTrials.gov
• Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin#140959ClinicalTrials.gov
• Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes Mellitus#143800ClinicalTrials.gov
• Ertugliflozin vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)#152354ClinicalTrials.gov
• Effect of Dihydromirycetin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes Mellitus#180332ClinicalTrials.gov
• A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes Mellitus#184815ClinicalTrials.gov
• Effect of Extra Virgin Olive Oil on Postprandial Blood Glucose in Type 2 Diabetes Mellitus Patients#201710ClinicalTrials.gov
• Efficacy of Mifepristone in Males With Type 2 Diabetes Mellitus#226174ClinicalTrials.gov
• A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus#230377ClinicalTrials.gov
• To Assess the Risk of Acute Pancreatitis in Patients With Type 2 Diabetes Mellitus Treated With Empagliflozin#245452ClinicalTrials.gov
• Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D#272272ClinicalTrials.gov
• An Observational Study on Efficacy and Safety in Subjects Using Levemir® for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes#162368ClinicalTrials.gov
• Cellular Adaptations to Training in Patients With Type 2 Diabetes#126050ClinicalTrials.gov
• Type 2 Diabetes Haptoglobin Phenotype and Vitamin E#141179ClinicalTrials.gov
• Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes#143812ClinicalTrials.gov